tetradecanoylphorbol acetate has been researched along with atorvastatin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonardo, B; Deprez-Beauclair, P; Juhan-Vague, I; Laouenan, H; Lopez, S; Nalbone, G; Peiretti, F | 1 |
| Bruegel, M; Stein, O; Stein, Y; Teupser, D; Thiery, J | 1 |
| Brown, AP; Corot, C; Gillard, JH; Graves, MJ; Lancelot, E; Müller, K; Patterson, AJ; Skepper, JN; Tang, TY; Thompson, PW | 1 |
| Hill, JS; Qiu, G | 1 |
| Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Storelli, C; Zampolli, A | 1 |
| Belo, VA; Gerlach, RF; Guimaraes, DA; Izidoro-Toledo, TC; Tanus-Santos, JE | 1 |
| Jaji, MS; Krishnan, UM; Kulkarni, NM; Mookkan, J; Muley, MM; Narayanan, S; Raghul, J; Rajesh, NB; Reddy, NK; Vijaykanth, G; Vishwakarma, SL | 1 |
| Gerlach, RF; Guimaraes, DA; Meschiari, CA; Pinheiro, LC; Tanus-Santos, JE | 1 |
| Cai, X; Huang, W; Huang, Z; Kong, F; Lin, L; Ye, B | 1 |
9 other study(ies) available for tetradecanoylphorbol acetate and atorvastatin
| Article | Year |
|---|---|
Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesis in human monocytes/macrophages.
Topics: Atorvastatin; Heptanoic Acids; HL-60 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Monocytes; Plasminogen Activator Inhibitor 1; Pyrroles; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Topics: Anticholesteremic Agents; Atorvastatin; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Gene Expression; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lipopolysaccharide Receptors; Monocytes; NF-kappa B; Pyridines; Pyrroles; Receptors, LDL; RNA, Messenger; Simvastatin; Tetradecanoylphorbol Acetate; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2001 |
Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
Topics: Atorvastatin; Cells, Cultured; Contrast Media; Dextrans; Dose-Response Relationship, Drug; Ferrosoferric Oxide; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Iron; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Nanoparticles; Oxides; Particle Size; Pyrroles; Tetradecanoylphorbol Acetate | 2008 |
Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
Topics: Atorvastatin; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Line; Cholesterol; DNA-Binding Proteins; Dose-Response Relationship, Drug; Foam Cells; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Liver X Receptors; Macrophage Activation; Macrophages; Orphan Nuclear Receptors; Pyrroles; Receptors, Cytoplasmic and Nuclear; rhoA GTP-Binding Protein; RNA, Messenger; Tetradecanoylphorbol Acetate | 2008 |
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Topics: ADP Ribose Transferases; Angiogenesis Inhibitors; Atorvastatin; Botulinum Toxins; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Enzyme Inhibitors; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 9; Mevalonic Acid; Neovascularization, Physiologic; Nitrobenzenes; Polyisoprenyl Phosphates; Pyrroles; rho GTP-Binding Proteins; RNA, Messenger; Simvastatin; Sulfonamides; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2010 |
Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.
Topics: Atorvastatin; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pravastatin; Pyrroles; Simvastatin; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Umbilical Veins | 2011 |
Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation.
Topics: Animals; Atorvastatin; Cell Proliferation; Cytokines; Dermatitis; Dose-Response Relationship, Drug; Ear, External; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Psoriasis; Skin; Tetradecanoylphorbol Acetate | 2015 |
Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin.
Topics: Atorvastatin; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Down-Regulation; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 9; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Phosphorylation; Signal Transduction; Sildenafil Citrate; Sodium Nitrite; Tetradecanoylphorbol Acetate; Transcription Factor RelA | 2016 |
Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
Topics: Apoptosis; Atorvastatin; Cell Line; Cell Survival; Humans; Inflammasomes; Macrophages; Monocytes; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Tetradecanoylphorbol Acetate; Toll-Like Receptor 4 | 2016 |